Michigan Split-belt Treadmill Training Program to Improve Long-Term Knee Biomechanics After ACL Reconstruction
Launched by UNIVERSITY OF MICHIGAN · Jul 26, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new training program using a split-belt treadmill to see if it can improve how the knee functions after ACL (anterior cruciate ligament) surgery. Specifically, the study aims to understand if different training methods can help change the way the knee loads during movement, which may lead to better recovery. Researchers will be looking at 9 participants who will be divided into three groups: two groups will receive different types of treadmill training, while one group will not receive any special training (the placebo group).
To be eligible for this study, participants should be aged between 14 and 45, have recently suffered a complete ACL tear confirmed by medical imaging, and have had surgery to repair it within the last 10 months. Participants will be asked to commit to testing and follow-up as part of the study. The researchers hope that this pilot data will help shape future clinical trials, ultimately improving recovery for patients who have undergone ACL reconstruction.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged 14-45 years
- • suffered an acute, complete ACL rupture as confirmed by MRI and physical exam
- • have undergone ACL reconstruction w autograft within the past 10 months
- • willingness to participate in testing and follow-up as outlined in the protocol
- • English-speaking
- Exclusion Criteria:
- • inability to provide written informed consent
- • female subjects who are pregnant or are planning to become pregnant (self-reported)
- • previous ACL injury
- • previous surgery to either knee
- • bony fracture accompanying ACL injury
- • patients who experienced a knee dislocation
- • patients who had their ACL reconstructed with an allograft
- • patients who underwent a multi-ligamentous and/or staged ACL reconstruction
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Riann M Palmieri-Smith, PhD, ATC
Principal Investigator
University of Michigan
Chandramouli Krishnan, PT, PhD
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported